A Clinical Trial to Evaluate the Efficacy and Safety of Recombinant Human Thrombopoietin in the Treatment of Thrombocytopenia After Chemotherapy in Acute Myeloid Leukemia
Phase of Trial: Phase IV
Latest Information Update: 29 Mar 2019
Price : $35 *
At a glance
- Drugs Thrombopoietin (Primary)
- Indications Thrombocytopenia
- Focus Therapeutic Use
- 21 Mar 2019 Status changed from recruiting to completed.
- 23 Jan 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 23 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.